RXRA c.29-31359T>C

Variant ID: 9-137262119-T-C

NM_002957.4(RXRA):c.29-31359T>C

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.

Science Advances
Ma, Xiao X; Zhu, Ping P; Ding, Yonghe Y; Zhang, Hong H; Qiu, Qi Q; Dvornikov, Alexey V AV; Wang, Zheng Z; Kim, Maengjo M; Wang, Yong Y; Lowerison, Matthew M; Yu, Yue Y; Norton, Nadine N; Herrmann, Joerg J; Ekker, Stephen C SC; Hsiai, Tzung K TK; Lin, Xueying X; Xu, Xiaolei X
Publication Date: 2020-01

Variant appearance in text: rs11185662
PubMed Link: 32064346
Variant Present in the following documents:
  • Main text
  • aay2939.pdf
View BVdb publication page



Genetic variants in the vitamin D pathway and breast cancer disease-free survival.

Carcinogenesis
Pande, Mala M; Thompson, Patricia A PA; Do, Kim-Anh KA; Sahin, Aysegul A AA; Amos, Christopher I CI; Frazier, Marsha L ML; Bondy, Melissa L ML; Brewster, Abenaa M AM
Publication Date: 2013-03

Variant appearance in text: rs11185662
PubMed Link: 23180655
Variant Present in the following documents:
  • Main text
View BVdb publication page